Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
25 4월 2024 - 9:00PM
Standard BioTools Inc. (“Standard BioTools” or the “Company”)
(Nasdaq: LAB) today announced that it will report first quarter
2024 financial results on Wednesday, May 8, 2024, after the
close of the market.
The Company’s management will host a conference
call and webcast at 1:30 p.m. PT, 4:30 p.m. ET, on May 8,
2024, to discuss first quarter 2024 financial results and
operational progress. A press release including the financial
results will be publicly distributed before the call.
Individuals interested in listening to the
conference call may do so by dialing:
US domestic callers: (888) 346-3970Outside US
callers: (412) 902-4297
Live audio of the webcast will be available online
on the Investor Relations page of the Company’s website
at Events & Presentations. The webcast will be archived
and available on Standard BioTools™ Investor Relations page
at investors.standardbio.com.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq:LAB), the parent
company of SomaLogic Inc. and previously known as Fluidigm
Corporation, is driven by a bold purpose – Unleashing tools to
accelerate breakthroughs in human health. Standard BioTools has an
established portfolio of essential, standardized next-generation
technologies that help biomedical researchers develop medicines
faster and better. As a leading solutions provider, the company
provides reliable and repeatable insights in health and disease
using its proprietary mass cytometry and microfluidics
technologies, which help transform scientific discoveries into
better patient outcomes. Standard BioTools works with leading
academic, government, pharmaceutical, biotechnology, plant and
animal research and clinical laboratories worldwide, focusing on
the most pressing needs in translational and clinical research,
including oncology, immunology and immunotherapy. Learn more at
standardbio.com or connect with us on X, Facebook®, LinkedIn, and
YouTube™.
For Research Use Only. Not for use in diagnostic
procedures.
Limited Use Label License and other terms may
apply: www.standardbio.com/legal/salesterms. Patent and License
Information: www.standardbio.com/legal/notices. Trademarks:
www.standardbio.com/legal/trademarks. Any other trademarks are the
sole property of their respective owners. ©2024 Standard BioTools
Inc. (f.k.a. Fluidigm Corporation). All rights reserved.
Investor Contact:
David HolmesGilmartin Group
LLCir@standardbio.com
Standard BioTools (NASDAQ:LAB)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Standard BioTools (NASDAQ:LAB)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024